Terms: = Germ cell tumor AND BRCA1, BRCAI, 672, ENSG00000012048, IRIS, BRCC1, RNF53, PSCP AND Prognosis
168 results:
1. Postpartum Breast Cancer and Survival in Women With germline BRCA Pathogenic Variants.
Zhang Z; Ye S; Bernhardt SM; Nelson HD; Velie EM; Borges VF; Woodward ER; Evans DGR; Schedin PJ
JAMA Netw Open; 2024 Apr; 7(4):e247421. PubMed ID: 38639936
[TBL] [Abstract] [Full Text] [Related]
2. Development and external validation of dual online tools for prognostic assessment in elderly patients with high-grade glioma: a comprehensive study using SEER and Chinese cohorts.
Zhang H; Jiang X; Ren F; Gu Q; Yao J; Wang X; Zou S; Gan Y; Gu J; Xu Y; Wang Z; Liu S; Wang X; Wei B
Front Endocrinol (Lausanne); 2023; 14():1307256. PubMed ID: 38075045
[TBL] [Abstract] [Full Text] [Related]
3. Functional assay for assessment of pathogenicity of BAP1 variants.
Repo PE; Backlund MP; Kivelä TT; Turunen JA
Hum Mol Genet; 2024 Feb; 33(5):426-434. PubMed ID: 37956408
[TBL] [Abstract] [Full Text] [Related]
4. iris melanoma: Review of clinical features, risks, management, and outcomes.
Cherkas E; Kalafatis NE; Marous MR; Shields CL
Clin Dermatol; 2024; 42(1):62-70. PubMed ID: 37865279
[TBL] [Abstract] [Full Text] [Related]
5. The tumor Suppressor brca1/2, Cancer Susceptibility and Genome Instability in Gynecological and Mammary Cancers.
Oubaddou Y; Ben Ali F; Oubaqui FE; Qmichou Z; Bakri Y; Ameziane El Hassani R
Asian Pac J Cancer Prev; 2023 Sep; 24(9):3139-3153. PubMed ID: 37774066
[TBL] [Abstract] [Full Text] [Related]
6. Identification of an Ultra-High-Risk Subgroup of Neuroblastoma Patients within the High-Risk Cohort Using a Computed Tomography-Based Radiomics Approach.
Wang H; Chen X; Li T; Xie M; Qin J; Zhang L; Ding H; He L
Acad Radiol; 2024 Apr; 31(4):1655-1665. PubMed ID: 37714717
[TBL] [Abstract] [Full Text] [Related]
7. BAP1 mutations inhibit the NF-κB signaling pathway to induce an immunosuppressive microenvironment in uveal melanoma.
Zhang C; Wu S
Mol Med; 2023 Sep; 29(1):126. PubMed ID: 37710185
[TBL] [Abstract] [Full Text] [Related]
8. Development and validation of a nomogram for predicting survival in intermediate- and high-risk neuroblastoma of the Children's Oncology Group risk stratification.
Feng L; Kan Y; Wang W; Wang C; Zhang H; Xie P; Yang J
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16377-16390. PubMed ID: 37702807
[TBL] [Abstract] [Full Text] [Related]
9. Omission of Completion Lymph Node Dissection in Sentinel Node Biopsy Positive Head and Neck Cutaneous Melanoma Patients.
Kesmodel SB; Kronenfeld JP; Zhao W; Koru-Sengul T; Goel N; Weingrad DN; Hernandez-Aya L; Lutzky J; Feun L; Garland-Kledzik M; Crystal JS
Ann Surg Oncol; 2023 Nov; 30(12):7671-7685. PubMed ID: 37639029
[TBL] [Abstract] [Full Text] [Related]
10. Grade scoring system reveals distinct molecular subtypes and identifies KIF20A as a novel biomarker for predicting temozolomide treatment efficiency in gliomas.
Ye L; Tong S; Wang Y; Wang Y; Ma W
J Cancer Res Clin Oncol; 2023 Sep; 149(12):9857-9876. PubMed ID: 37248320
[TBL] [Abstract] [Full Text] [Related]
11. iris melanoma: Prognostication for metastasis.
Melendez-Moreno A; Yeşiltaş YS; Wrenn J; Singh AD
Surv Ophthalmol; 2023; 68(5):957-963. PubMed ID: 37207703
[TBL] [Abstract] [Full Text] [Related]
12. The prognostic role of mitotic rate in cutaneous malignant melanoma: Evidence from a multicenter study on behalf of the Italian Melanoma Intergroup.
Patuzzo R; Mattavelli I; Gallino G; Galeone C; Valeri B; Mocellin S; Del Fiore P; Ribero S; Mandalà M; Tauceri F; Lombardo M; Maurichi A;
Cancer; 2023 Aug; 129(15):2331-2340. PubMed ID: 37162404
[TBL] [Abstract] [Full Text] [Related]
13. Construction and Verification of an RNA-Binding Protein-Associated Prognostic Model for Gliomas.
Peng P; Chen ZR; Zhang XL; Guo DS; Zhang B; He XM; Wan F
Curr Med Sci; 2023 Feb; 43(1):156-165. PubMed ID: 36867360
[TBL] [Abstract] [Full Text] [Related]
14. Locally advanced choroidal melanoma with favorable molecular prognosis - case report.
Bălăşoiu AT; Ştefănescu-Dima AŞ; Bălăşoiu M; Ciurea RN; Muraru A; Dan AO; Simionescu CE
Rom J Morphol Embryol; 2022; 63(4):645-652. PubMed ID: 36808200
[TBL] [Abstract] [Full Text] [Related]
15. Inherited mutations in Chinese patients with upper tract urothelial carcinoma.
Wu J; Jin S; Gu C; Wei Y; Zhu Y; Necchi A; Shariat SF; Pan J; Gan H; Dai B; Zhang H; Shi G; Zhu Y; Shen Y; Zhu Y; Ye D
Cell Rep Med; 2023 Jan; 4(1):100883. PubMed ID: 36630951
[TBL] [Abstract] [Full Text] [Related]
16. The germline mutational landscape of genitourinary cancers and its indication for prognosis and risk.
Yang Y; Zhang G; Hu C; Luo W; Jiang H; Liu S; Yang H
BMC Urol; 2022 Nov; 22(1):196. PubMed ID: 36451132
[TBL] [Abstract] [Full Text] [Related]
17. Relationship between Fitzpatrick Skin Type and The Cancer Genome Atlas Classification with Melanoma-Related Metastasis and Death in 854 Patients at a Single Ocular Oncology Center.
Sen M; Card KR; Caudill GB; Spitofsky NR; Dockery PW; Zaloga AR; Zeiger JS; DeYoung CF; Hamou SJ; Shields CL
Ophthalmic Genet; 2022 Dec; 43(6):742-755. PubMed ID: 36369870
[TBL] [Abstract] [Full Text] [Related]
18. Phosphoproteomic Analysis Defines BABAM1 as mTORC2 Downstream Effector Promoting DNA Damage Response in Glioblastoma cells.
Kalpongnukul N; Bootsri R; Wongkongkathep P; Kaewsapsak P; Ariyachet C; Pisitkun T; Chantaravisoot N
J Proteome Res; 2022 Dec; 21(12):2893-2904. PubMed ID: 36315652
[TBL] [Abstract] [Full Text] [Related]
19. Evolutionary Trajectories of Primary and Metastatic Pancreatic Neuroendocrine tumors Based on Genomic Variations.
Xu M; Yan J; Hu B; Wu C; Gu H; Qi Z; Chen T; Yang W; Zheng Y; Dong H; Sheng W; Long J
Genes (Basel); 2022 Sep; 13(9):. PubMed ID: 36140756
[TBL] [Abstract] [Full Text] [Related]
20. Pan-cancer analysis of the prognostic and immunological role of brca1-associated protein 1 gene (BAP1): Friend or foe?
Wang T; Zhu T; Zhang Y; Bai J; Xue Y; Xu G; Lu L; Peng Q
Gene; 2022 Oct; 840():146765. PubMed ID: 35905855
[TBL] [Abstract] [Full Text] [Related]
[Next]
